JP Morgan Chase’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $360K | Buy |
3,529
+41
| +1% | +$4.37K | ﹤0.01% | 5202 |
|
|
2025
Q4 | $360K | Sell |
3,488
-253,497
| -99% | -$24.7M | ﹤0.01% | 5224 |
|
|
2025
Q3 | $23.2M | Buy |
256,985
+1,148
| +0.4% | +$101K | ﹤0.01% | 1975 |
|
|
2025
Q2 | $22.5M | Buy |
255,837
+247,171
| +2,852% | +$21.4M | ﹤0.01% | 1872 |
|
|
2025
Q1 | $790K | Sell |
8,666
-2,650
| -23% | -$239K | ﹤0.01% | 4497 |
|
|
2024
Q4 | $976K | Buy |
11,316
+1,774
| +19% | +$160K | ﹤0.01% | 4650 |
|
|
2024
Q3 | $907K | Sell |
9,542
-146,021
| -94% | -$13.9M | ﹤0.01% | 4527 |
|
|
2024
Q2 | $14.2M | Buy |
155,563
+49,051
| +46% | +$4.38M | ﹤0.01% | 2147 |
|
|
2024
Q1 | $9.66M | Sell |
106,512
-51,626
| -33% | -$4.52M | ﹤0.01% | 2519 |
|
|
2023
Q4 | $12.9M | Sell |
158,138
-45,051
| -22% | -$3.53M | ﹤0.01% | 2224 |
|
|
2023
Q3 | $16.2M | Buy |
203,189
+150,365
| +285% | +$12.1M | ﹤0.01% | 1854 |
|
|
2023
Q2 | $4.16M | Buy |
52,824
+1,739
| +3% | +$136K | ﹤0.01% | 3020 |
|
|
2023
Q1 | $3.97M | Buy |
51,085
+50,497
| +8,588% | +$3.89M | ﹤0.01% | 3007 |
|
|
2022
Q4 | $46K | Buy |
+588
| New | +$43.4K | ﹤0.01% | 5651 |
|
|
2019
Q4 | – | Sell |
-100,880
| Closed | -$5.74M | – | 5833 |
|
|
2019
Q3 | $5.74M | Buy |
100,880
+100,000
| +11,364% | +$5.73M | ﹤0.01% | 2593 |
|
|
2019
Q2 | $51K | Hold |
880
| – | – | ﹤0.01% | 5159 |
|
|
2019
Q1 | $53K | Sell |
880
-907
| -51% | -$53.6K | ﹤0.01% | 5107 |
|
|
2018
Q4 | $98K | Sell |
1,787
-82
| -4% | -$4.97K | ﹤0.01% | 4860 |
|
|
2018
Q3 | $120K | Sell |
1,869
-80
| -4% | -$4.99K | ﹤0.01% | 4882 |
|
|
2018
Q2 | $115K | Hold |
1,949
| – | – | ﹤0.01% | 4789 |
|
|
2018
Q1 | $111K | Hold |
1,949
| – | – | ﹤0.01% | 4559 |
|
|
2017
Q4 | $116K | Sell |
1,949
-200
| -9% | -$11.5K | ﹤0.01% | 4619 |
|
|
2017
Q3 | $123K | Sell |
2,149
-150
| -7% | -$8.52K | ﹤0.01% | 4246 |
|
|
2017
Q2 | $136K | Buy |
2,299
+50
| +2% | +$2.83K | ﹤0.01% | 4085 |
|
|
2017
Q1 | $124K | Sell |
2,249
-250,057
| -99% | -$13.6M | ﹤0.01% | 4238 |
|
|
2016
Q4 | $13.2M | Buy |
252,306
+250,000
| +10,841% | +$13.4M | ﹤0.01% | 1736 |
|
|
2016
Q3 | $133K | Sell |
2,306
-688
| -23% | -$41.3K | ﹤0.01% | 3798 |
|
|
2016
Q2 | $175K | Sell |
2,994
-90
| -3% | -$5.25K | ﹤0.01% | 3757 |
|
|
2016
Q1 | $177K | Sell |
3,084
-75
| -2% | -$4.44K | ﹤0.01% | 3643 |
|
|
2015
Q4 | $206K | Sell |
3,159
-1,234
| -28% | -$79.7K | ﹤0.01% | 3646 |
|
|
2015
Q3 | $277K | Buy |
4,393
+45
| +1% | +$3.16K | ﹤0.01% | 3601 |
|
|
2015
Q2 | $308K | Buy |
4,348
+622
| +17% | +$44.8K | ﹤0.01% | 3710 |
|
|
2015
Q1 | $262K | Buy |
+3,726
| New | +$253K | ﹤0.01% | 3744 |
|
|
2014
Q1 | – | Sell |
-106,981
| Closed | -$5.68M | – | 3859 |
|
|
2013
Q4 | $5.68M | Buy |
106,981
+15,328
| +17% | +$776K | ﹤0.01% | 2091 |
|
|
2013
Q3 | $4.38M | Buy |
91,653
+10,676
| +13% | +$506K | ﹤0.01% | 2276 |
|
|
2013
Q2 | $3.68M | Buy |
+80,977
| New | +$3.74M | ﹤0.01% | 2355 |
|
Other funds holding PPH
BCIM
ERSOT
JSAM
TRCT
AT